Syngene to acquire plant from Stelis Biopharma for Rs 702 crore
The company has entered into a binding term sheet with Stelis to acquire its Bengaluru-based Unit 3 biologics manufacturing unit, Syngene said in a late night statement on Tuesday.
from Moneycontrol Business News https://ift.tt/ZP6j4Yd
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn
Nuffield College and Oxford City Council have submitted plans for a massive mixed-use neighbourhood on the brownfield city centre Oxpens site, with the joint venture also hunting for a developer. from Property Week - Latest Residential News https://ift.tt/4HVUvtp
The company has entered into a binding term sheet with Stelis to acquire its Bengaluru-based Unit 3 biologics manufacturing unit, Syngene said in a late night statement on Tuesday.
Comments
Post a Comment